Robert Wong

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

Désirée van der Heijde, Alan Kivitz, Michael Schiff et al. · Arthritis & Rheumatism · 2006 · 878 citations

Life Sciences, Immunology, Pharmacotherapy +13

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

Désirée van der Heijde, David Salonen, Barbara N. Weissman et al. · Arthritis Research & Therapy · 2009 · 412 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two

Hildrun Haibel, Martín Rudwaleit, Joachim Listing et al. · Arthritis & Rheumatism · 2008 · 315 citations

Medicine, Clinical Sciences, Internal Medicine +10

Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index

Walter P. Maksymowych, Charlotte Mallon, Scott Morrow et al. · Annals of the Rheumatic Diseases · 2008 · 281 citations

Medicine, Internal Medicine, Musculoskeletal Medicine +15

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Philip J. Mease, P A Ory, John T. Sharp et al. · Annals of the Rheumatic Diseases · 2008 · 267 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13